Model Medicines to Present at Wells Fargo Private Biotech Symposium

Dr. Daniel Haders, founder and CEO of Model Medicines will be participating in this year’s Wells Fargo Private Biotech Symposium, speaking to the recent announcement by the company around their Oncology Program.

Previous
Previous

Model Medicines to Present at Chem Together #4: Chemistry meets Artificial Intelligence

Next
Next

Model Medicines launches oncology programs targeting AXL and BRD4